P605: T-CELL PROLYMPHOCYTIC LEUKEMIA: MOLECULAR CHARACTERIZATION OF A COHORT OF 18 PATIENTS AND EVALUATION OF BORTEZOMIB AS A POSSIBLE THERAPEUTIC STRATEGY

• V. R. Gasparini,
• A. Martines,
• G. Barilà,
• A. Teramo,
• G. Calabretto,
• C. Vicenzetto,
• S. Carraro,
• V. Trimarco,
• L. Trentin,
• M. Facco,
• G. Semenzato,
• L. Bonaldi,
• R. Zambello

Affiliations

V. R. Gasparini

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine

A. Martines

2 Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova

G. Barilà

3 Hematology Unit, Ospedale dell’Angelo, Mestre-Venezia

A. Teramo

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine

G. Calabretto

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine

C. Vicenzetto

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine

S. Carraro

4 Department of Medicine, University of Padova, Padova, Italy

V. Trimarco

4 Department of Medicine, University of Padova, Padova, Italy

L. Trentin

4 Department of Medicine, University of Padova, Padova, Italy

M. Facco

4 Department of Medicine, University of Padova, Padova, Italy

G. Semenzato

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine

L. Bonaldi

2 Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova

R. Zambello

1 Department of Medicine, University of Padova and Veneto Institute of Molecular Medicine